Literature DB >> 7834833

Propafenone preferentially blocks the rapidly activating component of delayed rectifier K+ current in guinea pig ventricular myocytes. Voltage-independent and time-dependent block of the slowly activating component.

E Delpón1, C Valenzuela, O Pérez, O Casis, J Tamargo.   

Abstract

The effects of propafenone on the delayed rectifier K+ current were studied in guinea pig ventricular myocytes by using the patch-clamp technique. In these myocytes, this current consists of at least two components: a La(3+)-sensitive component activating rapidly with moderate depolarizations and a La(3+)-resistant current slowly activating at more positive potentials. In the absence of La3+ (when both components are present), propafenone inhibited the delayed outward current, its effects being more marked after weak than after strong depolarizations. Propafenone-induced block of the tail currents elicited on return to -30 mV was more marked after short than after long depolarizing pulses. In the presence of 1 mumol/L propafenone, the envelope-of-tails test was satisfied, thus indicating that at this concentration propafenone completely blocks the rapidly activating component. In the presence of La3+ (when only the slow component is present), the steady state inhibition induced by 5 mumol/L propafenone on both the maximum activated and the tail currents was independent of the test pulse voltage. Development of propafenone-induced block on the slowly activating component was very fast and linked to channel opening. In addition, the blockade appeared to be use dependent, with the rate constant of the onset kinetics at 2 Hz being 0.44 +/- 0.1 pulse-1. The recovery process from propafenone-induced block exhibited a time constant of 2.5 +/- 0.4 s. These results indicated that propafenone preferentially inhibits the rapidly activating component of the delayed rectifier and that it blocks in a voltage-independent and time-dependent manner the slow component of this current.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7834833     DOI: 10.1161/01.res.76.2.223

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

Review 1.  Slow delayed rectifier potassium current (IKs) and the repolarization reserve.

Authors:  Norbert Jost; Julius Gy Papp; András Varró
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-01       Impact factor: 1.468

2.  Mechanisms of block of a human cloned potassium channel by the enantiomers of a new bradycardic agent: S-16257-2 and S-16260-2.

Authors:  E Delpón; C Valenzuela; O Pérez; L Franqueza; P Gay; D J Snyders; J Tamargo
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Bupivacaine effects on hKv1.5 channels are dependent on extracellular pH.

Authors:  M Longobardo; T González; R Caballero; E Delpón; J Tamargo; C Valenzuela
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

4.  Effects of diltiazem and propafenone on the inactivation and recovery kinetics of fKv1.4 channel currents expressed in Xenopus oocytes.

Authors:  Dong Zhang; Shi-min Wang; Hui Chen; Xue-jun Jiang; Sheng-ping Chao
Journal:  Acta Pharmacol Sin       Date:  2011-04       Impact factor: 6.150

5.  Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels.

Authors:  Ricardo Gómez; Lucía Núñez; Ricardo Caballero; Miguel Vaquero; Juan Tamargo; Eva Delpón
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

6.  Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.

Authors:  Ashok A Paul; Harry J Witchel; Jules C Hancox
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

Review 7.  Cardiac Potassium Channels: Physiological Insights for Targeted Therapy.

Authors:  Kamalan Jeevaratnam; Karan R Chadda; Christopher L-H Huang; A John Camm
Journal:  J Cardiovasc Pharmacol Ther       Date:  2017-09-25       Impact factor: 2.457

8.  Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+.

Authors:  Zhiquan Wang; Shimin Wang; Jianjun Li; Xuejun Jiang; Neng Wang
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

9.  Inhibition of voltage-dependent K+ current in rabbit coronary arterial smooth muscle cells by the class Ic antiarrhythmic drug propafenone.

Authors:  Jin Ryeol An; Hongliang Li; Mi Seon Seo; Won Sun Park
Journal:  Korean J Physiol Pharmacol       Date:  2018-08-27       Impact factor: 2.016

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.